Status:
TERMINATED
Efficiency of Presurgical Basal Cell Carcinoma Margin Mapping
Lead Sponsor:
Michelson Diagnostics Ltd.
Collaborating Sponsors:
Skin Care Network Ltd.
Conditions:
Carcinoma, Basal Cell
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This Interventional Randomised Controlled study is intended to establish that presurgical margin mapping of BCCs with OCT results in a reduction of the number of MMS surgery stages without adversely i...
Detailed Description
Basal Cell Carcinoma (BCC) is the most common malignancy in humans. Its incidence is continuously increasing. The head and neck areas are most commonly affected due to their increased lifetime exposur...
Eligibility Criteria
Inclusion
- Patients with biopsy-proven BCCs who have been referred for MMS
Exclusion
- Patients with BCCs larger than 6 cm2
Key Trial Info
Start Date :
July 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2019
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT03420846
Start Date
July 1 2018
End Date
September 1 2019
Last Update
January 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SkinCare Network
London, United Kingdom, SW10 9PJ